These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 16638682
21. Formulation and evaluation of controlled release antibiotic biodegradable implants for post operative site delivery. Mathur V, Mudnaik R, Barde L, Roy A, Shivhare U, Bhusari K. Acta Pharm; 2010 Mar; 60(1):111-7. PubMed ID: 20228045 [Abstract] [Full Text] [Related]
22. In vivo wound healing performance of drug loaded electrospun composite nanofibers transdermal patch. Kataria K, Gupta A, Rath G, Mathur RB, Dhakate SR. Int J Pharm; 2014 Jul 20; 469(1):102-10. PubMed ID: 24751731 [Abstract] [Full Text] [Related]
23. Glycerogelatin-based ocular inserts of aceclofenac: physicochemical, drug release studies and efficacy against prostaglandin E₂-induced ocular inflammation. Mathurm M, Gilhotra RM. Drug Deliv; 2011 Jan 20; 18(1):54-64. PubMed ID: 20718601 [Abstract] [Full Text] [Related]
24. Ocular bioavailability of ciprofloxacin in sustained release formulations. Ke TL, Cagle G, Schlech B, Lorenzetti OJ, Mattern J. J Ocul Pharmacol Ther; 2001 Dec 20; 17(6):555-63. PubMed ID: 11777179 [Abstract] [Full Text] [Related]
25. Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers. Al-Kassas RS, El-Khatib MM. Drug Deliv; 2009 Apr 20; 16(3):145-52. PubMed ID: 19514974 [Abstract] [Full Text] [Related]
35. Nano-transfersomal ciprofloxacin loaded vesicles for non-invasive trans-tympanic ototopical delivery: in-vitro optimization, ex-vivo permeation studies, and in-vivo assessment. Al-Mahallawi AM, Khowessah OM, Shoukri RA. Int J Pharm; 2014 Sep 10; 472(1-2):304-14. PubMed ID: 24971692 [Abstract] [Full Text] [Related]
36. PREPARATION, IN VITRO AND IN VIVO CHARACTERIZATION OF HYDROPHOBIC PATCHES OF A HIGHLY WATER SOLUBLE DRUG FOR PROLONGED PLASMA HALF LIFE: EFFECT OF PERMEATION ENHANCERS. Yaqoob A, Ahmad M, Mahmood A, Sarfraz RM. Acta Pol Pharm; 2016 Nov 10; 73(6):1639-1648. PubMed ID: 29634120 [Abstract] [Full Text] [Related]
37. Formulation and In-Vitro Evaluation of Ocular Ciprofloxacin-Containing Minitablets Prepared with Different Combinations of Carbopol 974P and Various Cellulose Derivatives. Mortazavi SA, Jaffariazar Z, Damercheli E. Iran J Pharm Res; 2010 Nov 10; 9(2):107-14. PubMed ID: 24363715 [Abstract] [Full Text] [Related]
38. Electrospun formulations of acyclovir, ciprofloxacin and cyanocobalamin for ocular drug delivery. Baskakova A, Awwad S, Jiménez JQ, Gill H, Novikov O, Khaw PT, Brocchini S, Zhilyakova E, Williams GR. Int J Pharm; 2016 Apr 11; 502(1-2):208-18. PubMed ID: 26899973 [Abstract] [Full Text] [Related]
39. Biodegradable hybrid polymeric membranes for ocular drug delivery. Jain D, Carvalho E, Banerjee R. Acta Biomater; 2010 Apr 11; 6(4):1370-9. PubMed ID: 19900594 [Abstract] [Full Text] [Related]
40. Poly[LA-(Glc-Leu)] copolymer as a carrier for ocular delivery of ciprofloxacin: formulation, characterization and in vivo biocompatibility study. Pagar KP, Vavia PR. Ther Deliv; 2013 May 11; 4(5):553-65. PubMed ID: 23647274 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]